S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Sigma Labs Stock Forecast, Price & News

+0.03 (+0.76 %)
(As of 01/22/2021 12:00 AM ET)
Today's Range
Now: $4.00
50-Day Range
MA: $3.21
52-Week Range
Now: $4.00
Volume455,481 shs
Average Volume734,733 shs
Market Capitalization$30.83 million
P/E RatioN/A
Dividend YieldN/A
Sigma Labs, Inc. develops and commercializes manufacturing and materials technologies. The company offers PrintRite3D, an in-process-quality-assurance suite of software applications that embeds quality assurance and process control practices for metal-based additive manufacturing or 3D printing, and other advanced manufacturing technologies, as well as provides related engineering consulting services. It serves aerospace, defense, oil and gas, bio-medical, and power generation industries. The company was formerly known as Framewaves Inc. and changed its name to Sigma Labs, Inc. in September 2010. Sigma Labs, Inc. was incorporated in 1985 and is headquartered in Santa Fe, New Mexico.


Overall MarketRank

1.35 out of 5 stars

Business Services Sector

130th out of 442 stocks

Miscellaneous Manufacturing Industries Industry

8th out of 23 stocks

Analyst Opinion: 2.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Miscellaneous manufacturing industries
Current SymbolNASDAQ:SGLB



Sales & Book Value

Annual Sales$400,000.00
Book Value$0.46 per share


Net Income$-6,320,000.00
Net Margins-693.68%


Market Cap$30.83 million
Next Earnings Date3/23/2021 (Estimated)
OptionableNot Optionable
+0.03 (+0.76 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SGLB News and Ratings via Email

Sign-up to receive the latest news and ratings for SGLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sigma Labs (NASDAQ:SGLB) Frequently Asked Questions

How has Sigma Labs' stock been impacted by Coronavirus?

Sigma Labs' stock was trading at $4.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SGLB stock has decreased by 16.0% and is now trading at $4.00.
View which stocks have been most impacted by COVID-19

Is Sigma Labs a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sigma Labs in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sigma Labs stock.
View analyst ratings for Sigma Labs
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sigma Labs?

Wall Street analysts have given Sigma Labs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sigma Labs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Sigma Labs' CEO?

1,448 employees have rated Sigma Labs CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Sigma Labs' employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Sigma Labs' next earnings date?

Sigma Labs is scheduled to release its next quarterly earnings announcement on Tuesday, March 23rd 2021.
View our earnings forecast for Sigma Labs

How were Sigma Labs' earnings last quarter?

Sigma Labs, Inc. (NASDAQ:SGLB) posted its quarterly earnings data on Thursday, October, 22nd. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.08. The company earned $0.25 million during the quarter. Sigma Labs had a negative net margin of 693.68% and a negative return on equity of 182.86%.
View Sigma Labs' earnings history

What price target have analysts set for SGLB?

1 equities research analysts have issued twelve-month price objectives for Sigma Labs' stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate Sigma Labs' share price to reach $5.00 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price.
View analysts' price targets for Sigma Labs
or view Wall Street analyst' top-rated stocks.

Who are some of Sigma Labs' key competitors?

What other stocks do shareholders of Sigma Labs own?

Who are Sigma Labs' key executives?

Sigma Labs' management team includes the following people:
  • Mr. Darren Beckett, Chief Technology Officer (Age 46, Pay $180k)
  • Mr. Ronald Kenneth Fisher Jr., VP of Bus. Devel. (Age 50, Pay $180k)
  • Mr. Mark K. Ruport, Pres, CEO, Principal Exec. Officer & Director (Age 67)
  • Mr. Frank Donald Orzechowski, CFO, Treasurer & Corp. Sec. (Age 60)

What is Sigma Labs' stock symbol?

Sigma Labs trades on the NASDAQ under the ticker symbol "SGLB."

How do I buy shares of Sigma Labs?

Shares of SGLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sigma Labs' stock price today?

One share of SGLB stock can currently be purchased for approximately $4.00.

How big of a company is Sigma Labs?

Sigma Labs has a market capitalization of $30.83 million and generates $400,000.00 in revenue each year. Sigma Labs employs 21 workers across the globe.

What is Sigma Labs' official website?

The official website for Sigma Labs is www.sigmalabsinc.com.

How can I contact Sigma Labs?

Sigma Labs' mailing address is 3900 PASEO DEL SOL, SANTA FE NM, 87507. The company can be reached via phone at 505-438-2576 or via email at [email protected]

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.